Delivery Order SPE2DB20D3103-SPE2DB22FP5L4
Award Date 8/17/22
Potential Completion Date 8/18/22
Potential Value $8.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,501.32 firm fixed-price delivery order is for the supply of Xeljanz XR 11 MG Tablet, a prescription medication, with a performance period through May 9, 2025. This contract is not designated as a set-aside and is likely part of a larger indefinite delivery contract (IDC) valued at $999,999,999.00 that...
- This federal contract award, valued at $24,921.71, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xeljanz XR 11 mg tablets, a prescription medication used to treat various medical conditions. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,468.52 firm fixed-price delivery order contract is for the supply of XELJANZ XR 11 MG TABLET UU 30S, a medication used for various health conditions. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,419.92 firm fixed-price delivery order is for the supply of Xeljanz 5 mg tablets, a prescription medication. The contract has an ultimate completion date of September 24, 2024. Amerisourcebergen, the prime contractor, does not have any set-aside designation for this award. This delivery order is placed against a larger Indefinite Delivery...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, involves the supply of Xeljanz XR 11 mg tablets to the Defense Logistics Agency (DLA). The $20,764.15 firm-fixed-price delivery order has an ultimate completion date of August 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,863.33, is for the delivery of Xeljanz XR 11 mg tablets. It is a firm fixed-price delivery order contract with a completion date of September 20, 2023. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to AmerisourceBergen Drug Corp. in the amount of $48,279.03 for the delivery of Xeljanz XR 11 mg tablets. The contract has a ceiling value of $48,279.03 and an ultimate completion date of September 10, 2024. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, which serves as a primary vehicle for AmerisourceBergen to provide...
- This federal contract award, valued at $4,685.45, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xeljanz XR 11 mg tablets, a specialty medication used for various medical conditions. It is a firm-fixed-price delivery order with a completion date of March 7, 2022. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's...
- This federal contract award, issued by the Medical Supply Chain organization within the Defense Logistics Agency (DLA), was granted to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $26,268.10 firm fixed price delivery order is for the supply of Xeljanz XR 11 mg tablets to support military treatment programs and medical facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Xeljanz XR 11 mg tablet. The award has a ceiling value of $28,072.68 and a period of performance through April 16, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...